NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 05/05/2026 16:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization4,092.79 mln
Float176 mln
Earnings Date05/01/2026
EPS
0.22
Overpriced
P / E
60.95
Richly valued
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.76
Likely reliable
1-Year Forecast
17.00
Strong upside
Relative Strength
76
/ 100
Strongly outperforming
Business Description
Amneal Pharmaceuticals is a New Jersey-based company founded in 2002 that makes and sells a wide range of medicines across the United States and several other countries. Its portfolio includes affordable generic drugs, injectable treatments, biosimilars, and branded products targeting conditions such as Parkinson's disease and thyroid disorders. The company also supplies pharmaceuticals, medical products, and related services to government bodies including the Department of Defense and the Department of Veterans Affairs. Amneal reaches patients through pharmacies, hospitals, wholesalers, and managed care organizations.
